DiaMedica Therapeutics (DMAC) Change in Account Payables (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Change in Account Payables of $1.8 million for Q1 2026, up 220.63% year-over-year from $567000.0 in Q1 2025, and up 508.54% quarter-over-quarter from -$445000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Change in Account Payables (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 220.63% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 125.79% YoY), while the FY2025 annual figure was $535000.0, up 3721.43% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.8 million, up from -$445000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.8 million in Q1 2026, with the low at -$924000.0 in Q2 2023.
- The 5-year median for Change in Account Payables is $43000.0 (2024), against an average of $163764.7.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 5785.71% in 2024, then plunged 672.09% in 2025.
- DiaMedica Therapeutics' Change in Account Payables stood at -$130000.0 in 2022, then jumped by 148.46% to $63000.0 in 2023, then plunged by 466.67% to -$231000.0 in 2024, then tumbled by 92.64% to -$445000.0 in 2025, then surged by 508.54% to $1.8 million in 2026.
- Business Quant data shows DMAC's Change in Account Payables at $1.8 million in Q1 2026, -$445000.0 in Q4 2025, and $659000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | -481,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -481,000.00 |
| Jun 30, 2026 | -481,000.00 |
| Mar 31, 2026 | 1.82 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | -445,000.00 |
| Dec 31, 2025 | -445,000.00 |
| Sep 30, 2025 | 659,000.00 |
| Sep 30, 2025 | 659,000.00 |
| Jun 30, 2025 | -246,000.00 |
| Jun 30, 2025 | -246,000.00 |
| Mar 31, 2025 | 567,000.00 |
| Mar 31, 2025 | 567,000.00 |
| Dec 31, 2024 | -231,000.00 |
| Dec 31, 2024 | -231,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 43,000.00 |
| Mar 31, 2024 | -210,000.00 |
| Mar 31, 2024 | -210,000.00 |